Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.770
+0.030 (1.72%)
At close: May 20, 2025, 4:00 PM
1.710
-0.060 (-3.40%)
After-hours: May 20, 2025, 5:03 PM EDT
Q32 Bio Stock Forecast
QTTB's stock price has decreased by -94.17% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for Q32 Bio stock ranges from a low of $3.00 to a high of $95. The average analyst price target of $24 forecasts a 1,255.93% increase in the stock price over the next year.
Price Target: $24.00 (+1,255.93%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for Q32 Bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 5 | 5 | 3 | 3 | 3 | 3 |
Hold | 3 | 3 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +747.46% | Mar 12, 2025 |
BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | +69.49% | Feb 11, 2025 |
Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | +125.99% | Feb 11, 2025 |
BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +1,142.94% | Dec 12, 2024 |
Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.28
from -6.58
EPS Next Year
-4.31
from -4.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -4.14 | -2.40 | -3.33 |
Avg | -4.28 | -4.31 | -5.50 |
Low | -4.25 | -5.17 | -7.04 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.